| 23. | Advent Partners GPE VII - A Cayman Limited Partnership, a limited partnership organized under the laws of the Cayman Islands; |
| 24. | Advent Partners GPE VII - A Limited Partnership, a Delaware limited partnership; |
| 25. | GPE VII ATI Co-Investment (Delaware) Limited Partnership (“Advent Co-Invest Fund”), a Delaware limited partnership; |
The entities listed in subparagraphs (5) through (10) above are herein collectively referred to as “Advent Luxembourg Funds.” The entities listed in subparagraphs (12) through (14) above are herein collectively referred to as “Advent Cayman Funds.” The entities listed in subparagraphs (16) through (24) above are herein collectively referred to as “Advent AP Funds”, and together with the Advent Luxembourg Funds, the Advent Cayman Funds and Advent Co-Invest Fund, the “Advent Funds.”
Wilco GP, an affiliate of Advent, is the General Partner of Wilco Acquisition. Advent is the manager of Advent Top GP, which in turn is the General Partner of each of Advent GP Cayman, the Advent AP Funds, and the Advent Co-Invest Fund. Advent Top GP is also the manager of Advent GP Luxembourg, which is the General Partner of each of the Advent Luxembourg Funds. Advent GP Cayman is the General Partner of each of the Advent Cayman Funds.
The address of the principal business and the principal office of the Reporting Persons is Prudential Tower, 800 Boylston Street, Boston, Massachusetts 02199-8069.
The name, business address, present principal occupation or employment and citizenship of each director and executive officer (including a director and officer who may be a controlling person) of Advent is set forth on Schedule A to this Statement.
During the last five years, none of the Reporting Persons or, to the knowledge of the Reporting Persons, any of the persons listed on Schedule A attached hereto have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. A joint filing agreement among the Reporting Persons is attached as Exhibit 1 to this Statement and incorporated herein by reference.
Item 4. | Purpose of Transaction |
Item 4 of the Schedule 13D is supplemented as follows:
On November 24, 2021, Wilco Acquisition distributed 127,468,397 shares of Common Stock, pro rata and in-kind to its partners, for no consideration (the “Distribution”). In connection with the Distribution, the Advent Funds received the shares set forth in Item 5 below.
Item 5. | Interest in Securities of the Issuer |
Item 5 of the Schedule 13D is supplemented as follows:
The information set forth or incorporated by reference in Items 2 and 6 of this Statement is incorporated by reference in this Item 5.
(a) and (b) The responses of the Reporting Persons to rows (7) through (13) of the cover pages of this Schedule 13D, as of November 24, 2021, are incorporated herein by reference. As of November 24, 2021, the Reporting Persons beneficially owned in the aggregate 118,662,259 shares of Common Stock, which represents approximately 57.2% of the outstanding shares.